Our Experts

Experts committed to your success

With offices in Denmark, Germany, Sweden and the Netherlands, and more than 150 highly qualified staff, all with solid industry experience, we can assemble a team of experts to support the efficient advancement of your project.

Get in contact
Klifo, Glostrup. 07/10-2025

Senior Advisors

KLIFO provides access to a wide range of senior advisors across the drug development value chain. They can complement your project with specific competencies.
In order to get in touch with any of these senior advisors, please use our contact form (Button with “contact” – leading to contact page).





Senior Non-Clinical Advisors

  • Achim Orzechowski
  • Andrew Makin
  • Annsofi Nihlen
  • Geertje Lewin
  • Ingrid Bøgh
  • Line Hartvig
  • Lotte Martoft
  • Per Nedergaard
  • Roman Föll

Senior CMC Advisors

  • Anders Vagnø Pedersen
  • Babak Jamali
  • Erik Steffensen
  • Finn Wiberg
  • Jens Bukrinski
  • Julia E. Diederichs
  • Kaare Gyberg Rasmussen
  • Kaare Lund
  • Karen Rørbæk
  • Karin Liltorp
  • Lars Foldager
  • Lars Gyldenvang
  • Marianne Svärd
  • Mats Reslow
  • Timo Schmidt

Senior Medical Writer

  • Hanne Bendixen
  • Carsten Roepstorff

Senior Regulatory Advisors

  • Hanne Jensen
  • Mette Theilade

Senior QA Advisors

  • Anders Nyberg, GCP
  • Siglinde Duerr, GMP

Senior Medical Advisors

  • Gabor Liposits
  • Inger Christine Munch
  • Jan Harry Petersen
  • Klaus Stöhr
  • Lars Jelstrup Petersen
  • Maria Bech
  • Mikael Thomsen
  • Peter Nissen Bjerring
  • Ulrik Mouritzen

Senior Market Access Advisors

  • Tine Jørgensen

Senior Statistical Advisors

  • Thomas Bengtsson
  • Ulla Ivens

Senior PV Advisors

  • Hans Mosberg

Patent Strategy Advisors

  • Lars Bo Kjerrumgaard

About

Within Northern Europe, KLIFO ranks among the foremost consultancies in drug development. We offer consulting and operational services across all areas of drug development. We have significant experience in partnering with international companies across pharmaceutical and biotech industries.
We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance concerning the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution.
With offices in Denmark, Germany, Sweden and the Netherlands, and more than 150 highly qualified staff, all with solid industry experience, we can assemble a team of experts to support the efficient advancement of your project.
Our project teams represent the full breadth of expertise, competences and experience for successfully taking our clients’ drug development projects from discovery to market.
No matter the phase, scale or therapy area, our experts can help plan, manage and execute your drug development project. Whether your organisation is challenged with time, resources or expertise, we can assemble a team of relevant expert consultants to assist you.
You can insource our consultants to your organisation or outsource your project to us. Our solutions are based on close collaboration with you and your colleagues. We strive to build flexible and trust-based partnerships in which we work as an integrated part of your team.
Through collaboration, we can harness our combined expertise and ensure proper project implementation to ensure that your organisation benefits in both the short and long term.

We offer end to end solutions across all drug development areas

At KLIFO, we bring the competence and experience to carry your drug-development project from discovery all the way to market. Our expert consultants deliver tailored, end-to-end solutions — no matter the phase, scale, or therapeutic area. If your organisation faces constraints in time, resources, or in-house expertise, we can rapidly assemble a dedicated team to support you. Through close collaboration, we develop customised strategies and execute them with precision and trust, helping you turn great science into medicine.

Collaboration

At KLIFO we believe in collaboration, both internally among our staff and together with the companies we partner with. Only through collaboration is it possible to foresee and mitigate the many complexities associated with developing a new medical drug or bringing products to market.

Flexibility

Each and every drug development process is unique – acknowledging and embracing this is key to successfully bringing a new product to market. At KLIFO our starting point is to always listen to our clients’ needs and aspirations and based on this we can develop customised and efficient solutions.

Trust

The drug development process can take many years and the path can be costly and complex. Yet, at KLIFO we always have confidence in each other’s capacity, and this helps us to stay positive and develop novel solutions, also when faced with a difficult challenge. We have the same approach to working with our clients; building trust-based relationships plays a pivotal role in how we work.

Competence

Each milestone along the drug development journey requires unique skills and special expertise. KLIFO always strives to attract and retain the leading experts from all fields of drug development. We invest in our people and encourage their growth and development, so they can continue to offer the best possible solutions for our clients.